Heron Therapeutics
HRTX
#8256
Rank
NZ$0.41 B
Marketcap
NZ$2.27
Share price
0.00%
Change (1 day)
-18.27%
Change (1 year)

Heron Therapeutics (HRTX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$25.76 Million

According to Heron Therapeutics's latest financial reports the company has NZ$25.76 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Heron Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$59.67 Million11.07%
2023-12-31$-NZ$53.73 Million-351.31%
2022-12-31$NZ$21.37 M-81.18%
2021-12-31$NZ$0.11 B-65.35%
2020-12-31$NZ$0.32 B-45.34%
2019-12-31$NZ$0.59 B8.66%
2018-12-31$NZ$0.55 B198.86%
2017-12-31$NZ$0.18 B-701.86%
2016-12-31$-NZ$30.68 Million-117.78%
2015-12-31$NZ$0.17 B114.41%
2014-12-31$NZ$80.48 M-4.07%
2013-12-31$NZ$83.89 M33.19%
2012-12-31$NZ$62.98 M212.09%
2011-12-31$NZ$20.18 M1083.2%
2010-12-31$NZ$1.7 M-81.77%
2009-12-31$NZ$9.35 M-28.54%
2008-12-31$NZ$13.09 M-65.97%
2007-12-31$NZ$38.47 M124.79%
2006-12-31$NZ$17.11 M88.61%
2005-12-31$NZ$9.07 M-54.25%
2004-12-31$NZ$19.83 M14.48%
2003-12-31$NZ$17.32 M-41.34%
2002-12-31$NZ$29.53 M-36.02%
2001-12-31$NZ$46.16 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Alkermes
ALKS
NZ$3.00 B 11,545.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
NZ$1.25 B 4,785.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.14 B 471.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$1.64 B 6,283.41%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
NZ$0.19 B 647.79%๐Ÿ‡บ๐Ÿ‡ธ USA